Intuitive Surgical (NASDAQ:ISRG) EVP Sells $27,556.75 in Stock

Intuitive Surgical, Inc. (NASDAQ:ISRG) EVP Mark Brosius sold 61 shares of Intuitive Surgical stock in a transaction on Monday, October 26th. The stock was sold at an average price of $451.75, for a total transaction of $27,556.75. Following the transaction, the executive vice president directly owned 703 shares of the company’s stock, valued at approximately $317,580.25. This trade represents a 7.98% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan.

Mark Brosius also recently made the following trade(s):

• On Wednesday, October 28th, Mark Brosius sold 61 shares of Intuitive Surgical stock. The stock was sold at an average price of $441.60, for a total transaction of $26,937.60.
• On Friday, September 11th, Mark Brosius sold 25 shares of Intuitive Surgical stock. The shares were sold at an average price of $365.79, for a total transaction of $9,144.75.
• On Wednesday, September 9th, Mark Brosius sold 23 shares of Intuitive Surgical stock. The shares were sold at an average price of $350.20, for a total transaction of $8,054.60.
• On Tuesday, September 8th, Mark Brosius sold 46 shares of Intuitive Surgical stock. The stock was sold at an average price of $361.23, for a total value of $16,616.58.
• On Friday, August 21st, Mark Brosius sold 77 shares of Intuitive Surgical stock. The stock was sold at an average price of $375.57, for a total value of $28,918.89.
• On Wednesday, August 19th, Mark Brosius sold 77 shares of Intuitive Surgical stock. The shares were sold at an average price of $394.26, for a total transaction of $30,358.02.
• On Monday, August 17th, Mark Brosius sold 77 shares of Intuitive Surgical stock. The stock was sold at an average price of $390.67, for a total value of $30,081.59.
• On Friday, July 31st, Mark Brosius sold 28 shares of Intuitive Surgical stock. The shares were sold at an average price of $351.00, for a total transaction of $9,828.00.

Intuitive Surgical Trading Down 3.7%

Shares of Intuitive Surgical stock opened at $432.01 on Friday. The firm’s 50 day moving average is $401.54 and its 200 day moving average is $434.05. The firm has a market capitalization of $149.75 billion, a PE ratio of 52.24, a price-to-earnings-growth ratio of 3.09 and a beta of 1.46. Intuitive Surgical, Inc. has a 1 year low of $328.57 and a 1 year high of $603.88.

Intuitive Surgical (NASDAQ:ISRG) last issued its earnings results on Tuesday, October 20th. The medical equipment provider reported $3.00 earnings per share for the quarter, beating analysts’ consensus estimates of $2.65 by $0.35. Intuitive Surgical had a net margin of 25.54% and a return on equity of 18.17%. The firm had revenue of $3.05 billion for the quarter, compared to analyst estimates of $2.91 billion. During the same quarter last year, the business posted $2.40 earnings per share. The company’s quarterly revenue was up 21.7% on a year-over-year basis. As a group, research analysts anticipate that Intuitive Surgical, Inc. will post 9.37 earnings per share for the current year.

Analyst Ratings Changes

A number of equities research analysts have weighed in on the stock. Wall Street Zen raised shares of Intuitive Surgical from a “hold” rating to a “buy” rating in a report on Saturday. BNP Paribas Exane upgraded shares of Intuitive Surgical to an “outperform” rating in a report on Tuesday, July 28th. Oppenheimer reissued an “outperform” rating and issued a $500.00 price objective on shares of Intuitive Surgical in a research note on Wednesday, October 21st. Raymond James Financial reaffirmed an “outperform” rating and set a $480.00 target price on shares of Intuitive Surgical in a report on Wednesday, October 21st. Finally, Zacks Research raised Intuitive Surgical from a “hold” rating to a “strong-buy” rating in a research note on Thursday, October 22nd. One equities research analyst has rated the stock with a Strong Buy rating, twenty-three have issued a Buy rating, five have given a Hold rating and one has assigned a Sell rating to the company’s stock. Based on data from MarketBeat.com, the stock currently has a consensus rating of “Moderate Buy” and a consensus price target of $493.54.

Institutional Investors Weigh In On Intuitive Surgical

Several hedge funds and other institutional investors have recently modified their holdings of ISRG. Main Street Group LTD purchased a new stake in Intuitive Surgical in the first quarter worth $30,000. North Point Portfolio Managers Corp OH bought a new position in Intuitive Surgical during the third quarter worth about $27,000. John Boyer Inc. bought a new position in Intuitive Surgical during the third quarter worth about $27,000. Compass Wealth Management LLC bought a new stake in shares of Intuitive Surgical in the third quarter valued at approximately $29,000. Finally, Evergreen Advisors LLC purchased a new stake in shares of Intuitive Surgical during the 1st quarter valued at approximately $35,000. Institutional investors own 83.64% of the company’s stock.

Intuitive Surgical Company Profile

Intuitive Surgical, Inc develops and manufactures robotic-assisted systems and related technologies for minimally invasive surgery. Its products are designed to help surgeons perform procedures through small incisions while providing enhanced visualization, precision and control. The company’s primary platform is the da Vinci Surgical System, which is used across a range of specialties, including urology, gynecology, general surgery, cardiothoracic surgery and other procedures.

The company also offers the Ion endoluminal system, which is designed to support minimally invasive lung biopsy procedures.